tiprankstipranks
Trending News
More News >
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market

Shield Therapeutics (STX) Technical Analysis

Compare
42 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Shield Therapeutics PLC is a Buy.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 10.51, while Shield Therapeutics PLC’s (STX) share price is 9.85p, making it a Sell.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 10.25, while Shield Therapeutics PLC’s (STX) share price is 9.85p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

Feb 19, 2026, 04:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.21
9.67
10.08
10.54
10.96
11.42
11.83
Fibonacci
9.67
10.00
10.21
10.54
10.88
11.08
11.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Feb 19, 2026, 04:02 PM
Period
Simple
Exponential
MA5
10.45Sell
10.40Sell
MA10
10.39Sell
10.45Sell
MA20
10.46Sell
10.51Sell
MA50
10.69Sell
10.25Sell
MA100
9.21Buy
9.28Buy
MA200
6.83Buy
7.20Buy
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 10.45, while Shield Therapeutics PLC’s (STX) share price is 9.85p, making it a Sell.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 9.28, while Shield Therapeutics PLC’s (STX) share price is 9.85p, making it a Buy.
Shield Therapeutics PLC’s (STX) stock price is 9.85p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 10.69, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 9.85p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 9.21, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 9.85p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 6.83, creating a Buy signal.

Shield Therapeutics (STX) Technical Indicators

Feb 19, 2026, 04:02 PM
Name
Value
Implied Action
RSI (14)
45.75
Neutral
STOCH (9,6)
67.60
Neutral
STOCHRSI (14)
47.01
Neutral
MACD (12,26)
-0.05
Buy
ADX (14)
16.75
Buy
Williams %R
-62.02
Buy
CCI (14)
-49.12
Neutral
ATR (14)
1.02
-
Ultimate Oscillator
59.15
Neutral
ROC
-1.93
Sell
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 45.75, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 16.75, creating a Buy signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is -49.12, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is -1.93, creating a Sell signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Sell.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 45.75, which suggests STX is a Neutral.
      What is STX’s MACD?
      STX’s MACD is -0.05, which suggests STX is a Buy.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 10.45, which suggests STX is a Sell.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 10.46, which suggests STX is a Sell.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 10.69, which suggests STX is a Sell.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 6.83, which suggests STX is a Buy.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -62.02, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is -49.12, which suggests STX is a Neutral.
                    What is the share price of Shield Therapeutics PLC?